Eisler Capital (UK)’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$9.72M Sell
187,936
-17,245
-8% -$809K 0.04% 280
2024
Q2
$8.52M Buy
205,181
+53,430
+35% +$2.39M 0.05% 268
2024
Q1
$8.23M Buy
151,751
+63,402
+72% +$3.23M 0.07% 239
2023
Q4
$4.53M Buy
88,349
+72,041
+442% +$3.78M 0.04% 313
2023
Q3
$947K Buy
+16,308
New +$999K 0.01% 381

Other funds holding BMY

Eisler Capital (UK)'s BMY Position: Q3 2024 in Review

Eisler Capital (UK) reduced its Bristol-Myers Squibb (BMY) stake by 68% in Q3 2024, selling an estimated $1.11M and leaving 11,317 shares worth $586K. The position accounts for ﹤0.01% of the portfolio, ranked #522.

Eisler Capital (UK) first reported a position in BMY in Q4 2023 and has held it in 4 quarters since. The position peaked at $1.45M in Q2 2024. 2,259 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Eisler Capital (UK) held 11,317 shares of Bristol-Myers Squibb worth $586K as of Q3 2024.
  • Eisler Capital (UK) sold 23,602 Bristol-Myers Squibb shares in Q3 2024, an estimated $1.11M.
  • Bristol-Myers Squibb made up ﹤0.01% of Eisler Capital (UK)'s portfolio in Q3 2024, its #522 holding.
  • Eisler Capital (UK) first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 4 quarters since.
  • Eisler Capital (UK)'s Bristol-Myers Squibb position peaked at $1.45M in Q2 2024.
  • 2,259 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.